rs10237984

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015570.4(AUTS2):​c.310-66141G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.14 in 152,074 control chromosomes in the GnomAD database, including 2,368 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2368 hom., cov: 32)

Consequence

AUTS2
NM_015570.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0330

Publications

1 publications found
Variant links:
Genes affected
AUTS2 (HGNC:14262): (activator of transcription and developmental regulator AUTS2) This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014]
AUTS2 Gene-Disease associations (from GenCC):
  • autism spectrum disorder due to AUTS2 deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_015570.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015570.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AUTS2
NM_015570.4
MANE Select
c.310-66141G>T
intron
N/ANP_056385.1Q8WXX7-1
AUTS2
NM_001127231.3
c.310-66141G>T
intron
N/ANP_001120703.1Q8WXX7-2
AUTS2
NM_001127232.3
c.310-66141G>T
intron
N/ANP_001120704.1Q8WXX7-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AUTS2
ENST00000342771.10
TSL:1 MANE Select
c.310-66141G>T
intron
N/AENSP00000344087.4Q8WXX7-1
AUTS2
ENST00000406775.6
TSL:1
c.310-66141G>T
intron
N/AENSP00000385263.2Q8WXX7-2
AUTS2
ENST00000403018.3
TSL:1
c.310-66141G>T
intron
N/AENSP00000385572.2Q8WXX7-3

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21287
AN:
151956
Hom.:
2367
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.101
Gnomad AMR
AF:
0.208
Gnomad ASJ
AF:
0.0450
Gnomad EAS
AF:
0.538
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.102
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0625
Gnomad OTH
AF:
0.125
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.140
AC:
21300
AN:
152074
Hom.:
2368
Cov.:
32
AF XY:
0.148
AC XY:
11007
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.193
AC:
8014
AN:
41498
American (AMR)
AF:
0.208
AC:
3180
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0450
AC:
156
AN:
3470
East Asian (EAS)
AF:
0.539
AC:
2779
AN:
5156
South Asian (SAS)
AF:
0.302
AC:
1450
AN:
4806
European-Finnish (FIN)
AF:
0.102
AC:
1078
AN:
10564
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0625
AC:
4251
AN:
67990
Other (OTH)
AF:
0.127
AC:
267
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
838
1676
2514
3352
4190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0911
Hom.:
4712
Bravo
AF:
0.150
Asia WGS
AF:
0.399
AC:
1388
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.8
DANN
Benign
0.73
PhyloP100
0.033
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10237984;
hg19: chr7-69298131;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.